CIBRN Poll #4: Biosimilars have been available and used in other jurisdictions around the world. How long after a biosimilar has been introduced and used by patients in a real-world setting would you feel comfortable with its potential efficacy and safety?

If you haven’t yet participated in the poll, we invite you to share your views. Click here to answer.

Biosimilars have been available and used in other jurisdictions around the world. How long after a biosimilar has been introduced and used by patients in a real-world setting would you feel comfortable with its potential efficacy and safety?

  • Right away
  • A few months
  • 1 year
  • 2 years
  • 3 years
  • 5 years
  • Never

Click here to answer

CIBRN Poll #3: The introduction and promotion of biosimilar medications is fueled by a need to lower the overall cost of healthcare delivery. Where do you think we should be looking for cost savings?

If you haven’t yet participated in the poll, we invite you to share your views. Click here to answer.

The introduction and promotion of biosimilar medications is fueled by a need to lower the overall cost of healthcare delivery. Where do you think we should be looking for cost savings? Select one or more.

  • Hospitals
  • Physicians
  • Prescription Drugs
  • Long-term Care
  • Community Care
  • Other

Click here to answer